Literature DB >> 1293217

[Clinical study on symptoms in patients with strongyloidiasis].

O Zaha1, S Niimura, N Kinjo, M Ikema, H Nakamura, T Uehara, H Uechi, J Ohshiro, K Shikiya, F Kinjo.   

Abstract

We treated strongyloidiasis patients and obtained the following results: Of the 299 patients (184 males and 115 females), 81 patients (27.1%) had no complaints before treatment, 218 patients complaints of some symptoms, including arthralgia and/or lumbago (28.4%), abdominal pain and/or borborygmus (19.3%), numbness of extremities (18.1%), constipation (16.3%) and itching (15.7). We treated 219 patients with mebendazole and symptoms improved after treatment described below: Thirty-seven of the 63 patients (58.7%) with arthralgia and/or lumbago improved. Twenty-seven of the 36 patients (75.0%) with numbness of extremities improved. Thirty-one of the 32 patients (96.9%) with heartburn improved. We treated 26 patients with mebendazole plus thiabendazole and twelve of 14 patients (85.7%) with abdominal pain and/or borborygmus were improved after treatment. We treated 54 patients with ivermectin and five of 18 patients (27.8%) with arthralgia and/or lumbago were improved after treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1293217     DOI: 10.11150/kansenshogakuzasshi1970.66.1378

Source DB:  PubMed          Journal:  Kansenshogaku Zasshi        ISSN: 0387-5911


  2 in total

1.  Arthritis associated with Strongyloides stercoralis infection in HLA B-27-positive African.

Authors:  Joachim Richter; Irmela Müller-Stöver; Harald Strothmeyer; Klaus Göbels; Markus Schmitt; Dieter Häussinger
Journal:  Parasitol Res       Date:  2006-11       Impact factor: 2.289

2.  Morbidity Associated with Chronic Strongyloides stercoralis Infection: A Systematic Review and Meta-Analysis.

Authors:  Francesca Tamarozzi; Elisa Martello; Giovanni Giorli; Andrea Fittipaldo; Silvia Staffolani; Antonio Montresor; Zeno Bisoffi; Dora Buonfrate
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.